The trademark application Veylactin was filed by VEYX-Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 19, 2022, and it was registered by office on October 26, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).